Pic: Via getty
Top 10 at 10: Western Mines up 315% in two days as good news keeps flowing
News
share
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.
It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.
The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading.
WINNERS
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
| Code | Company | Price | % | Volume | Market Cap |
|---|---|---|---|---|---|
| ERA | Energy Resources | 0.15 | 216% | 1,500 | $175,370,233 |
| WMG | Western Mines | 0.475 | 51% | 2,289,665 | $12,925,238 |
| OJC | The Original Juice | 0.12 | 20% | 2,314 | $24,459,079 |
| MTB | Mount Burgess Mining | 0.003 | 20% | 3,802,143 | $2,207,928 |
| FG1 | Flynngold | 0.095 | 17% | 96,401 | $8,332,756 |
| ENN | Elanor Investors Grp | 1.73 | 17% | 106,383 | $182,414,091 |
| IMC | Immuron Limited | 0.081 | 16% | 545,295 | $15,945,884 |
| WGR | Westerngoldresources | 0.053 | 15% | 205,556 | $3,836,148 |
| BXN | Bioxyne Ltd | 0.025 | 14% | 25,000 | $14,644,199 |
| 4DX | 4Dmedical Limited | 0.585 | 14% | 1,016,678 | $151,663,296 |
Yesterday’s bolter Western Mines Group (ASX:WMG) says initial met test work on selected drilling at Mulga Tank suggests a high percentage of nickel in sulphide form.
“These very positive results offer encouragement to conduct further metallurgical beneficiation testwork to demonstrate the recovery of nickel sulphide into a high-grade saleable concentrate,” the company says.
“Broad intervals of shallow mineralisation, within the top 200 vertical metres, were deliberately selected for this initial testwork, which forms the first initial steps in demonstrating a viable large open pit scenario for the Mulga Tank Project.”
Elanor Investor Group (ASX:ENN) will buy Challenger’s (ASX:CGF) $3.4bn real estate funds management business for $41.8m in shares.
Dual listed biotech Immuron (ASX:IMC) reports Australia sales of $577,000 last quarter are up 201% on the entire first half of FY23.
Global Q3 YTD FY23 sales of A$1.46m represent an increase of 239% compared with the corresponding period in FY22.
LOSERS
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
| Code | Company | Price | % | Volume | Market Cap |
|---|---|---|---|---|---|
| CLZ | Classic Min Ltd | 0.001 | -50% | 23,685,641 | $4,874,879 |
| NOX | Noxopharm Limited | 0.067 | -39% | 544,984 | $32,146,175 |
| AQX | Alice Queen Ltd | 0.001 | -33% | 7,550,000 | $3,795,431 |
| CYP | Cynata Therapeutics | 0.215 | -19% | 83,263 | $37,968,297 |
| IVZ | Invictus Energy Ltd | 0.125 | -17% | 6,699,665 | $133,227,353 |
| CTO | Citigold Corp Ltd | 0.005 | -17% | 500,000 | $17,241,955 |
| RIE | Riedel Resources Ltd | 0.005 | -17% | 190,530 | $8,230,242 |
| SFG | Seafarms Group Ltd | 0.006 | -14% | 8,429,871 | $33,856,194 |
| RMX | Red Mount Min Ltd | 0.0035 | -13% | 3,150,000 | $9,087,404 |
| GLL | Galilee Energy Ltd | 0.14 | -13% | 740 | $54,166,000 |
